Emergent Biosolutions EBS Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total revenues by Business | ||||||
| Commercial Products | $223.7M-31.3% | $226.1M-43.3% | $252.8M-43.2% | $273.2M-44.4% | $325.7M-36.1% | |
| MCM Products | $401.9M-21.4% | $456.7M-10.4% | $474.3M-10.7% | $506M+8.9% | $511M-9.6% | |
| Segment adjusted gross margin reportable segments: by Business | ||||||
| Commercial Products | $91.5M-45.3% | $96.2M-54.8% | $116.3M-52.0% | $132.1M-52.2% | $167.4M-42.9% | |
| MCM Products | $256.2M-19.6% | $298.3M-2.0% | $293.9M-1.0% | $315.6M+50.4% | $318.5M+22.1% | |
| Total depreciation by Business | ||||||
| All other segment | $2M-79.2% | $3.7M-63.0% | $5.4M-58.9% | $7.4M-55.0% | $9.6M-50.7% | |
| MCM Products | $18.5M-1.6% | $18.1M-10.4% | $18.1M+12.4% | $18.1M-3.7% | $18.8M-9.2% | |
| Cost of goods and services sold by Business | ||||||
| Commercial Products | $132.2M-16.5% | $129.9M-30.1% | $136.5M-32.7% | $141.1M-34.6% | $158.3M-26.9% | |
| MCM Products | $145.7M-24.3% | $158.4M-22.9% | $180.4M-20.0% | $190.4M-23.9% | $192.5M-36.3% | |
| Total revenues by Product | ||||||
| All other revenue | $51.2M-60.2% | $60.1M-55.4% | $61.8M-58.3% | $72.4M-51.8% | $128.7M+22.5% | |
| Commercial Product sales | $223.7M-31.3% | $226.1M-43.3% | $252.8M-43.2% | $273.2M-44.4% | $325.7M-36.1% | |
| MCM Product sales | $401.9M-21.4% | $456.7M-10.4% | $474.3M-10.7% | $506M+8.9% | $511M-9.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Emergent Biosolutions break its business down?
- Emergent Biosolutions (EBS) reports total revenues by business across 2 parts — Commercial Products and MCM Products. Each is extracted from the segment footnotes and tracked over time.
- Where does Emergent Biosolutions's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Emergent Biosolutions's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
